However, the key factors in maternal circulation that regulate pregnancy-mediated changes in CYP3A activity in healthy pregnancies and those complicated by pregnancy-related conditions such as preeclampsia (that is frequently treated with the CYP3A substrate nifedipine) necessitate further study. This evidence concerns the gene CYP3A4 and preeclampsia.